| # | Title | Journal | Year | Citations |
|---|
| 1 | EAU Guidelines on Neurogenic Lower Urinary Tract Dysfunction | European Urology | 2009 | 429 |
| 2 | Liver cell death and anemia in Wilson disease involve acid sphingomyelinase and ceramide | Nature Medicine | 2007 | 406 |
| 3 | Phase II trial of titanocene dichloride in advanced renal-cell carcinoma | Cancer Chemotherapy and Pharmacology | 1998 | 228 |
| 4 | Extended Versus Limited Lymph Node Dissection in Bladder Cancer Patients Undergoing Radical Cystectomy: Survival Results from a Prospective, Randomized Trial | European Urology | 2019 | 197 |
| 5 | Clinical Relevance and Suppressive Capacity of Human Myeloid-Derived Suppressor Cell Subsets | Clinical Cancer Research | 2018 | 183 |
| 6 | Prognostic markers for bladder cancer: International Consensus Panel on bladder tumor markers | Urology | 2005 | 158 |
| 7 | Male-to-female transsexualism: a technique, results and long-term follow-up in 66 patients | BJU International | 2001 | 152 |
| 8 | A Systematic Review on the Role of Imaging in Early Recurrent Prostate Cancer | European Urology Oncology | 2019 | 140 |
| 9 | Clinical, prognostic, and therapeutic aspects of urachal carcinoma—A comprehensive review with meta-analysis of 1,010 cases | Urologic Oncology: Seminars and Original Investigations | 2016 | 119 |
| 10 | Impact of long-term androgen deprivation therapy on PSMA ligand PET/CT in patients with castration-sensitive prostate cancer | European Journal of Nuclear Medicine and Molecular Imaging | 2018 | 116 |
| 11 | Inverse relation of E-cadherin and autocrine motility factor receptor expression as a prognostic factor in patients with bladder carcinomas | Cancer Research | 1994 | 115 |
| 12 | Matrix metalloproteinase‐7 as a marker of metastasis and predictor of poor survival in bladder cancer | Cancer Science | 2010 | 92 |
| 13 | Results of89Strontium Therapy in Patients with Carcinoma of the Prostate and Incurable Pain from Bone Metastases: A Preliminary Report | Journal of Urology | 1976 | 87 |
| 14 | Saw palmetto extracts potently and noncompetitively inhibit human ?1-adrenoceptors in vitro | Journal of Urology | 1999 | 84 |
| 15 | Proposal for Systemic-Therapy Response-Assessment Criteria at the Time of PSMA PET/CT Imaging: The PSMA PET Progression Criteria | Journal of Nuclear Medicine | 2020 | 81 |
| 16 | Role of specialized composition of SWI/SNF complexes in prostate cancer lineage plasticity | Nature Communications | 2020 | 76 |
| 17 | Patient-derived xenografts and organoids model therapy response in prostate cancer | Nature Communications | 2021 | 76 |
| 18 | Prospective randomized double‐blind multicentre phase II study comparing gemcitabine and cisplatin plus sorafenib chemotherapy with gemcitabine and cisplatin plus placebo in locally advanced and/or metastasized urothelial cancer: SUSE (AUO‐AB 31/05) | BJU International | 2014 | 72 |
| 19 | Phase II Study: Adjuvant Single-Agent Carboplatin Therapy for Clinical Stage I Seminoma | European Urology | 1997 | 69 |
| 20 | Influence of androgen deprivation therapy on PSMA expression and PSMA-ligand PET imaging of prostate cancer patients | European Journal of Nuclear Medicine and Molecular Imaging | 2020 | 67 |
| 21 | Protein kinase C isoenzymes in rat and human cardiovascular tissues | British Journal of Pharmacology | 1997 | 63 |
| 22 | Gender comparison of muscarinic receptor expression and function in rat and human urinary bladder: differential regulation of M2 and M3 receptors? | Naunyn-Schmiedeberg's Archives of Pharmacology | 2003 | 59 |
| 23 | Gene signatures of testicular seminoma with emphasis on expression of ets variant gene 4 | Cellular and Molecular Life Sciences | 2005 | 55 |
| 24 | Comparison of human α1-adrenoceptor subtype coupling to protein kinase C activation and related signalling pathways | Naunyn-Schmiedeberg's Archives of Pharmacology | 1998 | 54 |
| 25 | Effects of ageing on muscarinic receptor subtypes and function in rat urinary bladder | Naunyn-Schmiedeberg's Archives of Pharmacology | 2005 | 54 |
| 26 | Does penile size in younger men cause problems in condom use? a prospective measurement of penile dimensions in 111 young and 32 older men | Urology | 2001 | 52 |
| 27 | Inhibitory Role of the Small Leucine-Rich Proteoglycan Biglycan in Bladder Cancer | PLoS ONE | 2013 | 49 |
| 28 | Enhanced stromal syndecan-1 expression is an independent risk factor for poor survival in bladder cancer | Human Pathology | 2014 | 49 |
| 29 | α1-Adrenoceptor Subtypes Differentially Couple to Growth Promotion and Inhibition in Chinese Hamster Ovary Cells | Biochemical and Biophysical Research Communications | 2000 | 48 |
| 30 | The prognostic value of cadherin switch in bladder cancer | Oncology Reports | 2010 | 48 |
| 31 | Mutations of KRAS, NRAS, BRAF, EGFR, and PIK3CA genes in urachal carcinoma: Occurence and prognostic significance | Oncotarget | 2016 | 45 |
| 32 | Angiogenic Switch of Angiopietins-Tie2 System and Its Prognostic Value in Bladder Cancer | Clinical Cancer Research | 2008 | 44 |
| 33 | Pathogenic and targetable genetic alterations in 70 urachal adenocarcinomas | International Journal of Cancer | 2018 | 44 |
| 34 | Validation of Circulating MMP-7 Level as an Independent Prognostic Marker of Poor Survival in Urinary Bladder Cancer | Pathology and Oncology Research | 2011 | 43 |
| 35 | High fibroblast-activation-protein expression in castration-resistant prostate cancer supports the use of FAPI-molecular theranostics | European Journal of Nuclear Medicine and Molecular Imaging | 2021 | 41 |
| 36 | Evaluation of an Unconventional Treatment Modality with Mistletoe Lectin to Prevent Recurrence of Superficial Bladder Cancer: A Randomized Phase ii Trial | Journal of Urology | 2002 | 40 |
| 37 | Elevated serum matrix metalloproteinase 7 levels predict poor prognosis after radical prostatectomy | International Journal of Cancer | 2011 | 39 |
| 38 | Soluble syndecan‐1 (SDC1) serum level as an independent pre‐operative predictor of cancer‐specific survival in prostate cancer | Prostate | 2016 | 39 |
| 39 | Diagnostic and prognostic value of long noncoding RNAs as biomarkers in urothelial carcinoma | PLoS ONE | 2017 | 39 |
| 40 | Intrinsic androgen-dependent gene expression patterns revealed by comparison of genital fibroblasts from normal males and individuals with complete and partial androgen insensitivity syndrome | BMC Genomics | 2007 | 38 |
| 41 | Severity of Urinary Incontinence of Nursing Home Residents Correlates with Malnutrition, Dementia and Loss of Mobility | Urologia Internationalis | 2013 | 38 |
| 42 | Biomarkers in Urachal Cancer and Adenocarcinomas in the Bladder: A Comprehensive Review Supplemented by Own Data | Disease Markers | 2018 | 38 |
| 43 | FAP imaging in rare cancer entities—first clinical experience in a broad spectrum of malignancies | European Journal of Nuclear Medicine and Molecular Imaging | 2022 | 35 |
| 44 | Serum Levels of Angiogenic Factors and their Prognostic Relevance in Bladder Cancer | Pathology and Oncology Research | 2009 | 32 |
| 45 | Urachal Carcinoma of the Bladder: Impact of Clinical and Immunohistochemical Parameters on Prognosis | Journal of Urology | 2016 | 32 |
| 46 | Circulating and tissue IMP3 levels are correlated with poor survival in renal cell carcinoma | International Journal of Cancer | 2019 | 32 |
| 47 | The Impact of the Receptor of Hyaluronan-Mediated Motility (RHAMM) on Human Urothelial Transitional Cell Cancer of the Bladder | PLoS ONE | 2013 | 32 |
| 48 | High insulin‐like growth factor mRNA‐binding protein 3 (IMP3) protein expression is associated with poor survival in muscle‐invasive bladder cancer | BJU International | 2012 | 31 |
| 49 | Limited versus extended pelvic lymphadenectomy in patients with bladder cancer undergoing radical cystectomy: Survival results from a prospective, randomized trial (LEA AUO AB 25/02). | Journal of Clinical Oncology | 2016 | 31 |
| 50 | Functional investigation of β-adrenoceptors in human isolated detrusor focusing on the novel selective β3-adrenoceptor agonist KUC-7322 | Naunyn-Schmiedeberg's Archives of Pharmacology | 2012 | 28 |
